The Multiple Myeloma Research Foundation Inc
The Multiple Myeloma Research Foundation Inc at a glance
In short: The Multiple Myeloma Research Foundation Inc gave $2.2M across 8 grants in 2025 (avg $271K), mostly in New York. Source: 2025 IRS Form 990.
- Annual giving (2025)
- $2,166,942
- -54.6% vs 2024
- Grants made (2025)
- 8
- -52.9% vs 2024
- Average grant
- $270,868
- -3.5% vs 2024
- Median grant
- $146,859
- Total assets
- $62,872,951
- -5.3% vs 2024
- Primary geography
- New York (53% of itemized 2025 grant dollars)
- Latest 990 filing
- Form 990, 2025 View filing
Data from IRS Form 990, 2025; updated September 2026.
Who The Multiple Myeloma Research Foundation Inc funds
How this funder distributes its grants
Top Recipients
Top 8 recipients in 2025
The largest 2025 recipient was Icahn School of Medicine at Mount Sinai ($1.1M). Together the top 8 received $2.2M.
Grant Size Distribution
89 grants across all recorded years
The most common grant size was under $50K: 37 grants of 89 (42%).
Geographic Focus
Where this funder awards grants
Grant Distribution by State
Share of 2025 grant dollars across all 8 itemized grants.
States
Cities
How The Multiple Myeloma Research Foundation Inc gives
- Giving fell 52% from 2022 to 2025. Method
From the foundation's IRS Form 990 filings. Methodology.
Giving History
Giving Over Time
Total grant dollars and number of grants per year
From 2020 to 2025, annual grant giving ranged from $1.8M (2020) to $6.6M (2023). In 2025 it made 8 grants totaling $2.2M.
Grants by year
Grant recipients and amounts by year
| Recipient | Purpose | Amount |
|---|---|---|
| Icahn School of Medicine at Mount Sinai New York, NY | Site Investment Grant, Mac Grant | $1,150,000 |
| University of Texas MD Anderson Cancer Center Houston, TX | Vlab Projects | $426,025 |
| Beckman Research Institute of City of Hope Duarte, CA | Site Investment Grant | $171,210 |
| Washington University in St Louis St. Louis, MO | Site Investment Grant | $157,300 |
| Beth Isreal Deaconess Medical Center Boston, MA | Fellow, Site Investment Grant | $136,418 |
| Indiana University Bloomington, IN | FELLOW | $60,000 |
| Trustees of Boston University Boston, MA | Scholars | $35,989 |
| University of Miami Coral Gables, FL | FELLOW | $30,000 |
Ready to take the next step with The Multiple Myeloma Research Foundation Inc?
Financial History
Multi-year comparison from IRS filings
| Filing year | Total Assets | Revenue | Expenses | Grants paid | Grants | Net Investment Income |
|---|---|---|---|---|---|---|
| 2025 | $62,872,951 | $36,523,356 | $34,651,131 | $2,166,942 | 8 | $1,150,050 |
| 2024 | $66,397,148 | $29,101,414 | $35,604,337 | $4,771,050 | 17 | $2,238,351 |
| 2023 | $80,227,632 | $33,950,590 | $41,890,829 | $6,594,759 | 21 | $1,692,518 |
| 2022 | $89,097,661 | $45,044,474 | $38,280,730 | $4,532,241 | 19 | $670,999 |
| 2021 | $85,401,847 | $42,311,196 | $37,647,063 | $6,582,783 | 24 | $2,872,478 |
| 2020 | $73,276,923 | $26,787,219 | $28,545,732 | $1,763,265 | 21 | $-1,530,381 |
About The Multiple Myeloma Research Foundation Inc
Based on IRS filings
The Multiple Myeloma Research Foundation Inc is a public charity focused on Diseases, Disorders & Medical Disciplines, based in Norwalk, CT. IRS filing data is available from 2020 through 2025. As of 2025, the organization holds $62.9M in total assets. In 2025, it awarded 8 grants totaling $2.2M. Net investment income was $1.2M.
Focus Areas
Leadership & Key People
Officers and directors from IRS filings
The Multiple Myeloma Research Foundation Inc is led by Michael Andreini, President & CEO since 2021 (on filings since 2020); 14 of 29 officers listed in 2025 are compensated.
Officers on the 2025 filing
Michael Andreini
President & CEO
COO → President & CEO, 2021
On filings since 2020
40 hrs/week
$279K (2020) → $535K (2025)
Thomas Conheeney
Chairman
Board Member → Director, 2021
Director → Chairman, 2022
On filings since 2020
2 hrs/week
No compensation reported
Stephanie Oestreich
Managing Director & Mif
On filings since 2024
40 hrs/week
$338K (2024) → $398K (2025)
Kathy Giusti
Founder & Director
Founder & Chief Mission Officer → Founder & Director, 2022
On filings since 2020
2 hrs/week
$457K (2020) → $0 (2025)
Joanne Puglia
Senior Director Finance & Controller
On filings since 2022
40 hrs/week
$186K (2022) → $200K (2025)
Ashley Blanchard
Senior Director & Strategic Partnerships
New on the 2025 filing
40 hrs/week
$190K (2025)
Francesca Larosa
Senior Director & Human Resources
New on the 2025 filing
40 hrs/week
$183K (2025)
Adrian Rosenkranz
Director
Board Member → Director, 2021
On filings since 2020
2 hrs/week
No compensation reported
David Lucchino
Director
Board Member → Director, 2021
On filings since 2020
2 hrs/week
No compensation reported
David Parkinson MD
Director
Board Member → Director, 2021
On filings since 2020
2 hrs/week
No compensation reported
Hugh Martin
Director
Board Member → Director, 2021
On filings since 2020
2 hrs/week
No compensation reported
Karen Andrews
Director
Board Member → Director, 2021
On filings since 2020
2 hrs/week
No compensation reported
Kenneth Anderson MD
Director
Board Member → Director, 2021
On filings since 2020
2 hrs/week
No compensation reported
Lori Tauber-Marcus
Director
Vice Chairman → Director, 2022
On filings since 2020
2 hrs/week
No compensation reported
Marie Pinizzotto MD
Director
Board Member → Director, 2021
On filings since 2020
2 hrs/week
No compensation reported
Rodney Gilmore
Director
Board Member → Director, 2021
On filings since 2020
2 hrs/week
No compensation reported
Steve Shak MD
Director
Board Member → Director, 2021
On filings since 2020
2 hrs/week
No compensation reported
William McKiernan
Director
Board Member → Director, 2021
On filings since 2020
2 hrs/week
No compensation reported
Kimberly White
Director
On filings since 2021
2 hrs/week
No compensation reported
Anne Quinn Young
Chief Mission Officer
Chief Marketing & Development Officer → Chief Mission Officer, 2022
On filings since 2020
40 hrs/week
$247K (2020) → $375K (2025)
Greg Rubenstein
Vice President of Marketing
On filings since 2020
40 hrs/week
$179K (2020) → $221K (2025)
Karen Dietz
Secretary, CAO & General Counsel
Secretary & In-House Counsel → Secretary CAO & General Counsel, 2022
Secretary CAO & General Counsel → Secretary, CAO & General Counsel, 2023
On filings since 2020
40 hrs/week
$206K (2020) → $287K (2025)
George Mulligan
Chief Scientific Officer
On filings since 2022
40 hrs/week
$234K (2022) → $371K (2025)
Hearn Cho
Chief Medical Officer
On filings since 2022
32 hrs/week
$209K (2022) → $228K (2025)
Katie Wozniak
Vice President of Clinical Research
On filings since 2023
40 hrs/week
$211K (2023) → $244K (2025)
Alan Heitner
Treasurer & CFO
On filings since 2024
40 hrs/week
$46K (2024) → $231K (2025)
Brian Hochberg
Principal Gift Officer
On filings since 2024
40 hrs/week
$177K (2024) → $185K (2025)
Pam Speer Lewis
Vice President of Development
New on the 2025 filing
40 hrs/week
$225K (2025)
Gerald McDougall
Vice Chairman
Board Member → Director, 2021
Director → Vice Chairman, 2022
On filings since 2020
2 hrs/week
No compensation reported
Former officers (22)
- Former: Christopher Williams (2020–2024) — Vice President of Alliance Management
- Former: Mark Hamilton (2020–2024) — Associate Director & Research
- Former: Michael Mortimer (2020–2024) — Director
- Former: Robert Miani (2020–2024) — Treasurer & CFO
- Former: Susan Marvin (2020–2024) — Director
- Former: Heather Steiger (2022–2024) — Senior Director Digital Marketing
- Former: Peter Kosa (2020–2023) — Mif Managing Director
- Former: Mindy Flinn (2021–2023) — Vice President of Development
- Former: Charles Volpe (2022–2023) — Director, Pr & Committee
- Former: Eva M. Lepisto (2022–2023) — Vice President of Informatics
- Former: Todd Brooks (2022–2023) — Senior Principal Gift Officer
- Former: Daniel Auclair (2020–2021) — Chief Scientific Officer
- Former: Michael Reinert (2020–2021) — Director
- Former: Paul Giusti (2020–2021) — Former President & CEO
- Former: Rodger Riney (2020–2021) — Director
- Former: Steven Labkoff MD (2020–2021) — Chief Data Officer
- Former: W. Dana Laforge (2020–2021) — Director
- Former: Catherine Wachira (2021) — Clincal Reseach
- Former: Chantelle Brinkley (2021) — Director & Office of the Founder
- Former: Karen Woolley (2020) — Clinical Operations Manager
- Former: Laura Gilman (2020) — Vice President of Events
- Former: Meryl Zausner (2020) — Board Member
Data from IRS Form 990 filings, 2020–2025. "On filings since" is the earliest filing we hold that lists the person; hours are average hours per week as reported.
Compensation Overview
From 2025 IRS filing
The highest reported compensation on the 2025 filing was $535K, to Michael Andreini (President & CEO). 14 officers or directors reported compensation on that filing.
Frequently asked questions about The Multiple Myeloma Research Foundation Inc
How much does The Multiple Myeloma Research Foundation Inc give each year?
The Multiple Myeloma Research Foundation Inc gave $2.2M across 8 grants in 2025, according to its 2025 IRS Form 990. In 2024 it gave $4.8M across 17 grants.
What is The Multiple Myeloma Research Foundation Inc's typical grant size?
The Multiple Myeloma Research Foundation Inc's median grant in 2025 was $146,859, and its average grant was $270,868, across 8 grants on its 2025 IRS Form 990.
Where does The Multiple Myeloma Research Foundation Inc give grants?
The Multiple Myeloma Research Foundation Inc gives mostly in New York: 53% of the grant dollars itemized on its 2025 IRS Form 990 went to recipients there. The next largest states were Texas (20%) and Massachusetts (8%). The most frequent recipient cities were Boston, MA (2 grants).
Does The Multiple Myeloma Research Foundation Inc give general operating support?
Not in 2025: none of the 8 grants with a stated purpose on The Multiple Myeloma Research Foundation Inc's 2025 IRS Form 990 were described as general or operating support.
Who are The Multiple Myeloma Research Foundation Inc's largest grantees?
The Multiple Myeloma Research Foundation Inc's largest 2025 grantees include Icahn School of Medicine at Mount Sinai ($1,150,000), University of Texas MD Anderson Cancer Center ($426,025) and Beckman Research Institute of City of Hope ($171,210), according to its 2025 IRS Form 990. Together they received 81% of its itemized 2025 grant dollars.
How large is The Multiple Myeloma Research Foundation Inc?
The Multiple Myeloma Research Foundation Inc reported $62.9M in total assets on its 2025 IRS Form 990. Its revenue that year was $36.5M.
What is The Multiple Myeloma Research Foundation Inc?
The Multiple Myeloma Research Foundation Inc is a public charity focused on Diseases, Disorders & Medical Disciplines, based in Norwalk, CT. It holds $62.9M in total assets as of 2025.
What is The Multiple Myeloma Research Foundation Inc's EIN?
The Multiple Myeloma Research Foundation Inc's EIN (Employer Identification Number) is 06-1504413. IRS Form 990 filing data is available on this page for 2020–2025.
Data last updated September 2026. Sourced from IRS Form 990 filings.
Data update history
(7)
When this profile's IRS filing data changed on Grantable
- Updated Form 990 for fiscal year 2020 (received by the IRS September 16, 2021)
- Updated Form 990 for fiscal year 2021 (received by the IRS November 8, 2022)
- Updated Form 990 for fiscal year 2022 (received by the IRS October 30, 2023)
- Updated Form 990 for fiscal year 2023 (received by the IRS September 24, 2024)
- Updated Form 990 for fiscal year 2024 (received by the IRS October 15, 2025)
- Added Form 990 for fiscal year 2025 (received by the IRS August 25, 2026)
- IRS filings on file for fiscal years 2020–2024
Live grants for the work The Multiple Myeloma Research Foundation Inc funds
Diseases, Disorders & Medical Disciplines Open opportunities, soonest deadline first.
Explore Open Grants
Browse active grant opportunities in The Multiple Myeloma Research Foundation Inc's focus areas in our free grants database
Similar Funders
Funders that support many of the same organizations
American Cancer Society Inc
Atlanta, GA
The American Cancer Society funds cancer research, patient support, and advocacy, including grants to researchers, institutions, and related organizations. Its 2025 grants ranged from $5,648 to $9.6 million, with a median of $15,000; research funding supports institutions across the United States. It accepts applications for specific research programs through ProposalCentral, but the profile does not state whether it accepts unsolicited requests generally.
Assets
$1.7B
Grants
509
Total Given
$23.1M
Conquer Cancer Foundation of the American Society of Clinical Oncology
Alexandria, VA
Conquer Cancer funds cancer research, professional education, and quality-care initiatives, with awards to universities, hospitals, and cancer centers in the U.S. and through international programs. Its 2024 grants ranged from $50,000 to $7.68 million, with a median of $100,000; the profile does not state whether it accepts unsolicited requests.
Assets
$120.7M
Grants
39
Total Given
$17.4M
Fred Hutchinson Cancer Center
Seatle, WA
Fred Hutchinson Cancer Center funds cancer and infectious disease research, along with Washington community-led projects in cancer prevention, screening, education, and care access. Research grants vary widely (the 2025 median was about $118,000); its community awards were up to $15,000, and Tribal Community Grants up to $50,000 plus indirect costs. Community programs are focused on Washington State; whether unsolicited requests are accepted is not stated.
Assets
$3.6B
Grants
139
Total Given
$88.2M
Seattle Children's Hospital
Seattle, WA
Seattle Children’s funds pediatric medical research, education, healthcare access, mental health and children’s health initiatives; its external Crossett Fund supports projects benefiting children and youth in Southeast Alaska. Its 2025 grants ranged from $5,326 to $15.3 million, with a median of $57,582, while Crossett awards are capped at $10,000. The Crossett Fund accepts applications year-round; other unsolicited requests are not described.
Assets
$6.0B
Grants
181
Total Given
$56.3M
National Alliance for Research on Schizophrenia and Depression
New York, NY
The Brain & Behavior Research Foundation funds scientific research into the causes, treatment, and prevention of serious mental illnesses, including schizophrenia, depression, anxiety, and bipolar disorder. Its 2024 grants had a median of about $70,000 and supported research institutions across multiple U.S. states; the Young Investigator program is explicitly U.S.-based. Applicants use award-specific application processes, but the profile does not state whether unsolicited requests are accepted.
Assets
$62.4M
Grants
80
Total Given
$8.4M
Emory University
Atlanta, GA
Emory University primarily funds research and subcontract work for universities, hospitals, research organizations, and other organizations, across a range of academic and health-related fields. Its 2025 grants ranged from $5,500 to $19.1 million, with a median of about $97,000; 41% of grant dollars went to Georgia recipients. The profile does not state whether Emory accepts unsolicited requests.
Assets
$24.9B
Grants
362
Total Given
$183.7M
More similar funders
More Funders in Connecticut
The filing figures on this page are open data under CC BY 4.0. About GrantGraph Open
Figures come from The Multiple Myeloma Research Foundation Inc's IRS filings (methodology). AI-written summaries, news items and logos are not covered by the open licence. Spot an error? Email hello@grantable.co.
The Multiple Myeloma Research Foundation Inc down — hundreds of funders to go?